Endomorphin-1 and endomorphin-2 induce the expression of c-FOS immunoreactivity in the rat brain

Brain Research

Volumn 873, Issue 2, 2000, Pages 291-296

  Jiang, Yuhui ^a   Klodesky, Carla M ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

c FOS; Endomorphin; Immunocytochemistry; Intracerebroventricular; Mu opioid receptor; Tail flick latency

Indexed keywords

ENDOMORPHIN 1; ENDOMORPHIN 2; PROTEIN C FOS; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN REGION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOREACTIVITY; MALE; NEUROMODULATION; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; TAIL FLICK TEST;

ANIMALS; BRAIN; NEURONS; OLIGOPEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 0034637269     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02537-3     Document Type: Article

References (20)

1. Bystzycka E.K., Nail B.S. Brain stem nucleus associated with respiratory, cardiovascular and other autonomic functions. Paxinos G. The Rat Nervous System: Hindbrain and Spinal Cord. Vol. II:1985;95-110 Academic Press, New York.
2. Chahl L.A., Leah J., Herdegen T., Truman T.L., Lynch-Frame A.M. Distribution of c-fos in guinea pig brain following morphine withdrawal. Brain Res. 717:1996;127-134.
3. Chapman V., Diaz A., Dickenson A.H. Distinct inhibitory effects of spinal endomorphin-1 and endomorphin-2 on evoked dorsal horn neuronal responses in the rat. Br. J. Pharmacol. 122:1997;1537-1539.
4. De Olmos J.S. The amygdaloid projection field in the rat as studied with the cupric-silver method. Eleftheriou B.E. The Neurobiology of Amygdaloid. 1978;145-204 Plenum Press, New York.
5. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Methods. 29:1989;261-265.
6. Goldberg I.E., Rossi G.C., Letchworth S.R., Mathis J.P., Ryan-Moro J., Leventhal L., Su W., Emmel D., Bolan E.A., Pasternak G.W. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J. Pharmacol. Exp. Ther. 286:1998;1007-1013.
7. Grant S.J., Huang Y.H., Redmond D.E. Jr. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation. Pharmacol. Biochem. Behavior. 30:1998;13-19.
8. Hiller J.M., Zhang Y., Bing G., Gioannini T.L., Stone E.A., Simon E.J. Immunohistochemical location of mu-opioid receptors in rat brain using antibodies generated against a peptides sequence present in a purified mu-opioid binding protein. Neuroscience. 62:1994;829-841.
9. Jackson A., Crossman A.R. Basal ganglia and other afferent projections to the peribrachial region in the rat: a study using retrograde and antegrade transport of horseradish peroxidase. Neuroscience. 6:1981;1537-1549.
10. Jacobson L., Sapolsky R. The role of the hippocampus in the feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrine Rev. 12:1991;118-134.
11. Martin-Schild S., Gerall A.A., Kastin A.J., Zadina J.E. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J. Comp. Neurol. 405:1999;450-471.
12. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, New York. 258.
13. Pasternak G.W. Opioid receptors. Meltzer H.Y. Psychopharmacology, the Third Generation of Progress. 1987;281-288 Raven Press, New York.
14. Peterson P.K., Gekker G., Hu S., Lokensgard J., Portoghese P.S., Chao C.C. Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology. 38:1999;273-278.
15. Sakurada S., Zadina J.E., Kastin A.J., Katsuyama S., Fujimura T., Murayama K., Yuki M., Ueda H., Sakurada T. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and-2-induced anti-nociception. Eur. J. Pharmacol. 372:1999;25-30.
16. Sanchez-Blazquez P., Rodriguez-Diaz M., DeAntonio I., Garzan J. Endomorphin-1 and endomorphin-2 show differences in their activation of mu-opioid receptor-regulated G proteins in supraspinal antinociception in mice. J. Pharmacol. Exp. Ther. 291:1999;12-18.
17. Stone L.S., Fairbanks C.A., Laughlin T.M., Nguyen H.O., Bushy T.M., Wessendorf M.W., Wilcox G.L. Spinal analgesic actions of the new endogenous opioid endomorphin-1 and-2. Neuroreport. 8:1997;3131-3135.
18. Chang S.L., Patel N.A., Romero A.A., Thompson J., Zadina J.E. FOS expression induced by interleukin-1 or acute morphine treatment in the rat hypothalamus is attenuated by chronic exposure to morphine. Brain Res. 736:1996;227-236.
19. Vinogradova O.S. Functional organization of the limbic system in the process of registration of information; facts and hypothesis. Isaacson R.L., Pribram K.H. The Hippocampus. Vol. 1:1975;3-69 Plenum Press, New York.
20. Zadina J.E., Hackler L., Ge L.J., Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 386:1997;499-502.